Aldeyra Therapeutics, Inc.
TREATMENT OF INFLAMMATORY DISORDERS
Last updated:
Abstract:
The present disclosure provides compounds and methods of use thereof for treating inflammatory diseases or disorders.
Status:
Application
Type:
Utility
Filling date:
24 May 2021
Issue date:
18 Nov 2021